Optimizing Melanoma Care to Improve Patient Outcomes

Join us for a series of short interactive, live-stream presentations for oncology nurses in our virtual Nursing Education Day (ie, NED Talks!) on melanoma. A panel of oncology nurse professionals will discuss therapeutic options for patients with melanoma, including adverse event management and nursing considerations for targeted therapies and immunotherapies. This event will offer attendees the opportunity to have their questions answered by the expert panel.

A virtual Nursing Education Day (NED) that includes short webinar presentations and scheduled audience question and answer sessions with panel discussions.

To Register: On the Event Dates page click a date/time, click blue Register button in upper right-hand corner. Once registered, you will receive a reminder email with a link to join in advance of the Webinar.

Agenda

Welcome and Introduction

  • NED Talk 1: Overview of Current Treatment Algorithms and Clinical Evidence for Adjuvant and Neoadjuvant Therapy Options
  • NED Talk 2: Caring for Patients With Melanoma and Targetable BRAF Alterations
  • NED Talk 3: Targeted Therapy Adverse Event Management and Experts’ Recommendations

Break: Audience Question and Answer Session

  • NED Talk 4: Immune Checkpoint Inhibitors in the Management of Metastatic Melanoma
  • NED Talk 5: Best Practices to Proactively Address Immune-Related Adverse Events and Optimizing Clinical Outcomes

Events

Date / Time
Event Details

Faculty

Faculty
Kathy Madden, RN, MSN, FNP-BC, AOCNP, APHN

Faculty
Suzanne McGettigan, MSN CRNP AOCN

Faculty
Krista M. Rubin, MSN, FNP-BC

Nurse Practitioner
Center for Melanoma
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, and oncology nurses surrounding recent improvements in the care of melanoma and in applying those improvements to their patients.

Target Audience
This educational program is intended for nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, and oncology nurses.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Review the clinical efficacy and safety profiles associated with targeted therapies and immunotherapies across the melanoma treatment settings
  • Recall current indications for targeted therapies and immunotherapies across the melanoma treatment settings
  • Develop a proactive management plan for early recognition and appropriate management of AEs associated with targeted and immunotherapies to support quality of life and continuation of treatment
  • Evaluate nursing strategies to optimize patient care, including—but not limited to—patient counseling for management of treatment-related AEs and the importance of adherence to treatment

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.